Skip to main content
Equibles
VTVT logo

VTVT · vTv Therapeutics Inc. · Holdings

Track VTVT — free

Use VTVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VTVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$25.72 -0.09 (-0.35%) At close · Oct 27
Rebalance outlook locked
Market Cap
$102.41M
Shares
3.95M
Volume · Oct 27 11.16K Avg daily vol (3M) 53.58K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Use institutional holdings through the 13F API or MCP → See every holder of VTVT: 13F, 13D and 13G, insiders and funds →
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 44
Total Value: $60,468,321
Total Shares: 1,606,165

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 45 13F filers
Top Holder
18.6%
Sep 2023 → Jun 2026 · range 18.6% – 62.0%
of institutional value
Top 5
70.9%
Sep 2023 → Jun 2026 · range 70.9% – 99.3%
of institutional value
Top 10
89.7%
Sep 2023 → Jun 2026 · range 89.7% – 100.0%
of institutional value
HHI
1,167
Sep 2023 → Jun 2026 · range 1,167 – 4,746
Broadly held

Who Holds VTVT

Last 8 quarters through Sep 30, 2026 (filing window open)

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Jun 30, 2026, the newest closed quarter: 45 filers, like-for-like change +8.1%; actively managed books +12.3%; index-like books -17.1%.

Holder type Share Filers Change
Registered adviser 59.2% 20 +17.1%
Exempt adviser 2.5% 1 +49.1%
Bank 1.3% 4 -40.3%
Non-US 0.1% 2 +16300.0%
Holding company 17.2% 4 -4.0%
Unknown 19.7% 14 -2.6%

The Sep 30, 2026 filing window is still open, so its bar carries the Jun 30, 2026 positions of filers that have not filed yet.

How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 1 holder with no observed 2026-06-30 13F.

Conviction and Crowding

45 13F filers, quarter ended Jun 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Mar 31, 2026: 0
Holders above 5%
0
median weight 0.000%
Mar 31, 2026: 0
Crowding
—
the issuer has more than one class of common stock, so its count is the total across classes
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
the issuer has more than one class of common stock, so its count is the total across classes
Top 10 holders
89.7%
of 13F shares, Herfindahl 0.117
Active holders
+12.3%
like-for-like share change of active filers
5% stakes on record
5
2 13D, 3 13G (0 institutional, 3 passive, 0 exempt)
How long holders have held it value-weighted 7.3 quarters
Under 1 year 42.2% 1 to 3 years 39.1% 3 years or more 18.7% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $1,733,770 (1 buying, 0 selling).

Estimated Holder Cost Basis

Quarter ended Jun 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$24.36
estimated per share
Mar 31, 2026: $22.51
Quarter-end price
$37.65
implied by 13F values
Estimated gain or loss
+54.6%
price against the estimated cost
Estimated at a loss
0.003%
of costed 13F value

Estimated cost covers 86.7% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies VTVT's active holders also own, quarter ended Jun 30, 2026
# Company Shared holders
1 NGNE Neurogene Inc. 3
2 DSGN Design Therapeutics, Inc. 3
3 PBLS Parabilis Medicines, Inc. 3
4 SRRK Scholar Rock Holding Corp 3
5 XENE Xenon Pharmaceuticals Inc. 3
6 CYTK Cytokinetics Inc 3
7 RVMD Revolution Medicines, Inc. 3

Shareholder Targets

13F filers that own its peers but not VTVT, quarter ended Jun 30, 2026

Found through its holder-overlap peers: NGNE, DSGN, PBLS, SRRK, XENE, CYTK, RVMD. 908 filers in all.

# Filer In peers
1 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $2,603,739,507 2 held
2 Jupiter Topco LLC Unknown, Diversified active $2,470,357,722 5 held
3 VANGUARD PORTFOLIO MANAGEMENT LLC Registered adviser, Diversified active $2,269,286,035 7 held
4 Darwin Global Management, Ltd. Exempt adviser, Concentrated $1,990,753,064 1 held
5 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $1,834,031,053 3 held
6 WELLINGTON MANAGEMENT GROUP LLP Holding company, Diversified active $1,767,612,634 6 held
7 Nextech Invest, Ltd. Exempt adviser, Concentrated $1,551,162,700 2 held
8 PRICE T ROWE ASSOCIATES INC /MD/ Registered adviser, Diversified active $1,205,553,621 7 held
9 Avoro Capital Advisors LLC Registered adviser, Concentrated $1,204,878,693 3 held
10 Paradigm Biocapital Advisors LP Registered adviser, Concentrated $1,191,348,571 1 held

Fund Ownership of VTVT by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 3.24% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.72% 28,627
Index ETFs 2.51% 99,399
Active ETFs 0.00% 0
Active funds 6.60% 260,877
Unclassified 0.00% 0
All registered funds 9.84% 388,903
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Holder type: Registered adviser 19 Exempt adviser 1 Bank 4 Non-US 2 Holding company 4 Unknown 14
Showing 44 of 44
All Common Calls Puts
Export CSV
Holder Value (USD) % of 13F Shares Open
SAMSARA BIOCAPITAL, LLC $11,238,374 18.59% 298,496
MILLENNIUM MANAGEMENT LLC $10,160,756 16.80% 269,874
FMR LLC $9,803,721 16.21% 260,391
Siren, L.L.C. $6,136,950 10.15% 163,000
BAKER BROS. ADVISORS LP $5,584,022 9.23% 148,314
VANGUARD CAPITAL MANAGEMENT LLC $3,556,531 5.88% 94,463
Trails Edge Capital Partners, LP $3,207,478 5.30% 85,192
Aisling Capital Management LP $1,882,500 3.11% 50,000
MARSHALL WACE, LLP $1,489,433 2.46% 39,560
GEODE CAPITAL MANAGEMENT, LLC $1,222,495 2.02% 32,470
RENAISSANCE TECHNOLOGIES LLC $657,143 1.09% 17,454
VANGUARD FIDUCIARY TRUST CO $611,398 1.01% 16,239
BlackRock, Inc. $554,621 0.92% 14,731
JANE STREET GROUP, LLC $515,917 0.85% 13,703
STATE STREET CORP $461,814 0.76% 12,266
TWO SIGMA INVESTMENTS, LP $432,447 0.72% 11,486
Verdad Advisers, LP $338,699 0.56% 8,996
Integrated Quantitative Investments LLC $309,106 0.51% 8,210
SUSQUEHANNA INTERNATIONAL GROUP, LLP $302,065 0.50% 8,023
Quadrature Capital Ltd $237,383 0.39% 6,305
Trexquant Investment LP $234,936 0.39% 6,240
NORTHERN TRUST CORP $230,530 0.38% 6,123
Pathstone Holdings, LLC $228,648 0.38% 6,073
Point72 Asset Management, L.P. $223,904 0.37% 5,947
HRT FINANCIAL LP $223,000 0.37% 5,923
CITADEL ADVISORS LLC $222,360 0.37% 5,906
China Universal Asset Management Co., Ltd. $94,125 0.16% 2,500
UBS Group AG $81,888 0.14% 2,175
BNP PARIBAS ARBITRAGE, SA $67,845 0.11% 1,802
Vanguard Global Advisers, LLC $48,003 0.08% 1,275
OSAIC HOLDINGS, INC. $38,403 0.06% 1,020
MORGAN STANLEY $37,987 0.06% 1,009
Farther Finance Advisors, LLC $8,727 0.01% 283
State of Wyoming $5,534 0.01% 147
Truvestments Capital LLC $5,383 0.01% 143
Strengthening Families & Communities, LLC $5,335 0.01% 173
BESSEMER GROUP INC $4,216 0.01% 112
Activest Wealth Management $1,542 0.00% 50
Parallel Advisors, LLC $1,430 0.00% 38
CoreCap Advisors, LLC $1,387 0.00% 45
ROYAL BANK OF CANADA $112 0.00% 3
Caitong International Asset Management Co., Ltd $75 0.00% 2
SBI Securities Co., Ltd. $61 0.00% 2
Strategic Wealth Partners, Ltd. $37 0.00% 1
Key facts CIK 1641489 CUSIP 918385204 13F (30d) 5 filings 5 filers Visit website Investor relations